Spirometers Market By Product Type (Desktop Spirometers, Handheld Spirometers), Technology (Volume Measurement Spirometers, Flow Measurement Spirometers), End-User (Hospitals and Clinics, Home Care Settings), & Region for 2024-2031

Spirometers Market Valuation – 2024-2031

The market’s expanding demand for spirometers is primarily driven by the rising prevalence of respiratory disorders and increased awareness about lung health. Asthma, chronic obstructive pulmonary disease (COPD), and other respiratory problems are growing more frequent around the world, thanks in part to air pollution, smoking, and an aging population. Spirometers are vital instruments for diagnosing and monitoring these illnesses since they measure lung function and assist healthcare practitioners in determining the severity of a patient’s respiratory problems by enabling the market to surpass a revenue of USD 1.00 Billion in 2024 and reach a valuation of around USD 2.45 Billion by 2031.

The combination of digital technology and telemedicine skills enables remote monitoring and data administration which is especially useful when managing chronic disorders such as COPD. Furthermore, many countries’ healthcare policies are shifting toward preventative treatment and chronic illness management pushing the use of spirometry as a standard aspect of respiratory health assessment. These developments not only make spirometry simpler and more efficient but also broaden its applications beyond typical healthcare settings meeting the growing demand for continuous and comprehensive respiratory care by enabling the market to grow at a CAGR of 11.87% from 2024 to 2031. 

To Get Detailed Analysis: Download Report PDF

Spirometers Market: Definition/ Overview

Spirometers are medical devices that measure the amount and rate at which a person may inhale and exhale air from their lungs. Spirometers evaluate lung function and are commonly used to diagnose and monitor respiratory illnesses such as asthma, chronic obstructive pulmonary disease (COPD), and other lung-related disorders. When a patient uses a spirometer, they usually breathe into a mouthpiece attached to the instrument which then records various elements of their breathing.

They are essential equipment in respiratory care, primarily used to measure lung function by measuring the amount of air a person can inhale and exhale as well as the pace of exhalation. Spirometers are primarily used to diagnose and monitor chronic respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Using a spirometer, healthcare personnel can assess how well the lungs are functioning allowing them to diagnose these diseases earlier.

The future use of spirometers is expected to grow dramatically as healthcare shifts toward more tailored and preventive care. Spirometers which evaluate lung function by determining the amount and rate of air a person can inhale and exhale are becoming increasingly useful in detecting and treating respiratory illnesses such as asthma, chronic obstructive pulmonary disease (COPD), and others. Spirometers are expected to become more incorporated into routine healthcare as technology advances making them more accessible and user-friendly.

What's inside a VMR
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=7656

Will the Growing Preference for Home Healthcare Drive the Spirometers Market?

The rising need for home healthcare is a primary driver of the spirometer market. An aging population, the demand for cost-effective healthcare solutions, and recent global health catastrophes have all contributed to the acceleration of this trend. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third biggest cause of death worldwide, killing 3.23 million people in 2019. With the increasing prevalence of respiratory disorders, there is a greater demand for home-based monitoring equipment such as spirometers. According to the Centers for Disease Control and Prevention (CDC), around 16 million Americans have been diagnosed with COPD, and millions more may remain untreated.

According to the American Thoracic Society, home spirometry may be especially useful for monitoring COVID-19 patients since it allows for early diagnosis of worsening lung function. Furthermore, Global Industry Insights predicts that the global telemedicine industry will reach USD 185.6 Billion by 2026 signaling a larger trend toward home-based healthcare solutions. This trend is projected to increase demand for portable, user-friendly spirometers that can interact with telehealth platforms.

Will Lack of Skilled Professionals Hamper the Spirometers Market?

The scarcity of skilled specialists is a major problem that may impede the growth of the spirometer market. Spirometry, a commonly used pulmonary function test is critical for identifying and monitoring respiratory illnesses such as asthma, chronic obstructive pulmonary disease (COPD), and other lung problems. A lack of such experienced workers, especially in rural or poor regions can result in erroneous test findings, misdiagnoses, and, ultimately, a reluctance among healthcare practitioners to use spirometry as a standard diagnostic tool.

The dilemma of a shortage of competent specialists is exacerbated by an increase in demand for spirometry testing as respiratory disorders become more prevalent around the world. As the population’s age and environmental factors such as pollution contribute to an increased incidence of lung disorders, the demand for spirometry testing is predicted to rise. However, without enough educated experts to administer these tests, healthcare systems may struggle to fulfill demand, resulting in longer patient wait times and perhaps inferior quality of care. This may dissuade healthcare providers from expanding their spirometry services or investing in new spirometers, thus impeding market growth.

Category-Wise Acumens

Will the Rise in Telemedicine and Remote Patient Monitoring Drive Growth in the Product Type Segment?

Handheld spirometers have become the dominant product type, thanks to their mobility, ease of use, and applicability in a variety of healthcare settings. Unlike desktop spirometers, which are typically used in clinical settings because of their size and complexity, handheld spirometers provide unrivaled ease. They allow healthcare providers to do lung function tests in a variety of places including hospitals, clinics, and even patients’ homes. This adaptability is especially useful in instances where immediate lung function evaluation is necessary such as during an emergency or in rural locations with limited access to advanced medical facilities.

The rise of telemedicine and remote patient monitoring has increased the demand for handheld spirometers. With an increased emphasis on patient-centered care and a growing tendency to decentralize healthcare services, these technologies have become indispensable instruments in modern medicine. Handheld spirometers are particularly appealing to healthcare providers and consumers due to their ease of transport and use in a variety of settings as well as their interaction with mobile devices and cloud-based health platforms. Furthermore, technical developments have enhanced the accuracy and utility of handheld spirometers bringing them on par with older desktop devices. This convergence of mobility, innovative features, and the growing need for remote health monitoring guarantees that handheld spirometers maintain their dominance in the spirometer industry, adapting to changing demands.

Will Versatility and Widespread Application Drive the Technology Segment?

Flow measurement spirometers are the leading technology in the spirometers market because of their precision, adaptability, and broad use in diagnosing and monitoring respiratory disorders. Flow-measuring spirometers are very useful in determining airway blockage which is an important factor in the diagnosis and treatment of chronic respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and other obstructive lung diseases. These devices assess the flow rate of air during various breathing maneuvers providing critical data on parameters such as Forced Expiratory Volume in one second (FEV1) and the FEV1/FVC ratio which are critical for determining the degree of airway obstruction.

The dominance of flow measurement spirometers is further supported by technological improvements that have enhanced their accuracy, usability, and integration with digital health platforms. Modern flow measuring spirometers are frequently portable and user-friendly with the ability to link to mobile devices or cloud-based systems enabling remote monitoring and telemedicine applications. This link has grown increasingly significant, particularly in the aftermath of the COVID-19 epidemic when the demand for remote patient monitoring and telehealth services increased. Furthermore, the continual development of software algorithms for analyzing spirometry data improves the diagnostic accuracy and predictive capacity of these devices making them more appealing to healthcare practitioners.

Gain Access into Spirometers Market Report Methodology

https://www.verifiedmarketresearch.com/select-licence/?rid=7656

Country/Region-wise Acumens

Will the Increasing Number of Asthma and COPD Cases Drive the Market in the North American Region?

The North American spirometer market is primarily driven by the rising prevalence of respiratory illnesses, particularly asthma and chronic obstructive pulmonary disease (COPD). This supremacy is due to the region’s high healthcare spending, superior medical infrastructure, and increased awareness of respiratory health issues. The increasing prevalence of asthma is a major driver of the North American spirometer market.

According to the Centers for Disease Control and Prevention (CDC), around 25 million Americans had asthma in 2019, including 5.1 million children. This constitutes around 7.8% of the overall population. Asthma imposes a significant economic burden with yearly expenses estimated at USD 81.9 Billion in the United States alone. The National Heart, Lung, and Blood Institute believes that another 12 million people may have undiagnosed COPD. The economic impact of COPD is also considerable, with direct healthcare expenses in the United States topping USD 32 Billion per year. According to the World Health Organization (WHO), nine out of ten people globally breathe polluted air.

Will Improving Primary Care Activities Drive the Market in the Asia Pacific Region?

The Asia Pacific region is expected to be the fastest-growing market for spirometers owing to rising healthcare costs and increased awareness of respiratory disorders. This tremendous expansion is being driven by several major factors that are transforming the healthcare environment throughout the area. The rising prevalence of respiratory disorders, particularly chronic obstructive pulmonary disease (COPD) and asthma, is a significant driver of the Asia Pacific spirometer market.

According to the World Health Organization, COPD is expected to become the third largest cause of mortality globally by 2030 with a considerable impact in Asia. In China, the prevalence of COPD among individuals aged 40 and over is estimated to be 13.7%, impacting approximately 100 million people.  Another key driver is increased healthcare spending and the improvement of healthcare infrastructure throughout the region. Furthermore, activities aimed at mitigating air pollution, particularly in developing-country cities are creating respiratory health concerns. According to the World Bank, air pollution costs South Asian countries an estimated 8.3% of their GDP, underscoring the economic incentive for governments to address this issue.

Competitive Landscape

The Spirometers Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the spirometers market include:

• Schiller
• Smiths Medical
• Vyaire Medical, Inc.
• SDI Diagnostics
• nSpire Health Inc.
• Fukuda Sangyo Co. Ltd.
• Sibelmed
• Vitalograph
• Geratherm Respiratory AG
• Koninklijke Philips N.V.
• Welch Allyn

 Latest Developments

• In March 2023, Clario and ArtiQ teamed up to incorporate artificial intelligence into clinical trial spirometry data gathering. This collaboration allowed for scalable AI over-reading while assuring accurate data collection and patient benefits in respiratory trials.
• In August 2022, AstraZeneca India collaborated with Alveofit to provide IoT-enabled handheld spirometers to clinics and last-mile hospitals.

Report Scope

Spirometers Market, By Category

Product Type:

• Desktop Spirometers
• Handheld Spirometers
• PC-Based Spirometers

Technology:

• Volume Measurement Spirometers
• Flow Measurement Spirometers

End-User:

• Hospitals and Clinics
• Home Care Settings
• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies

Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Research Methodology of Verified Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Research.

Reasons to Purchase this Report:

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.